CRISPR/Cas9‐mediated mutagenesis to validate the synergy...

Bioengineering & Translational Medicine 2020 / 01 Vol. 5; Iss. 1

CRISPR/Cas9‐mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1 ‐mutated breast cancer cells

Mintz, Rachel L., Lao, Yeh‐Hsing, Chi, Chun‐Wei, He, Siyu, Li, Mingqiang, Quek, Chai Hoon, Shao, Dan, Chen, Boyuan, Han, Jing, Wang, Sihong, Leong, Kam W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Language:
english
Journal:
Bioengineering & Translational Medicine
DOI:
10.1002/btm2.10152
Date:
January, 2020
File:
PDF, 3.52 MB
english, 2020
Conversion to is in progress
Conversion to is failed